The study will compare the Movano data to results captured with an FDA-cleared finger stick glucose tester, a subject’s existing CGM device, and/or a vital sign monitoring device.

The GIER feature is an audio-visual software module of guided imagery, relaxation and education, designed for optional use in conjunction with the REN treatments.

GenesisCare Chief Global Medical Officer, Dr. Wally Curran, adds: “GenesisCare’s participation in this clinical trial is one example of how we seek to increase access to innovative research that addresses each individual patient’s needs.

Prof Mark De Ridder, head of the radiotherapy department of UZ Brussel, Vrije Universiteit Brussel, Belgium said “This most recent TomoBreast trial analysis reinforces the outcomes seen in previous clinical evaluations and demonstrates the potential of the TomoTherapy System to make a meaningful difference in breast cancer patients’ daily lives.

“This first study demonstrated quick application and easy activation of the NPsealTM,” stated Machiel van der Leest, CEO of Guard Medical. “This ease of use combined with its cost effectiveness makes prophylactic use of NPWT for closed surgical wounds possible.”

Conducted by a coalition of organizations, including the National Institute for Dementia Education, the CERTUS Institute, Vivid-Pix, Tellegacy, and achi, the group studied the healing power of photos and concluded that Photo Reminiscence Therapy (pRT) can minimize social isolation and improve medication compliance and general cognitive performance.